Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond

Pharmacol Res. 2023 Nov:197:106982. doi: 10.1016/j.phrs.2023.106982. Epub 2023 Nov 3.

Abstract

In the aftermath of tissue injury or infection, an efficient resolution mechanism is crucial to allow tissue healing and preserve appropriate organ functioning. Pro-resolving bioactive lipids prevent uncontrolled inflammation and its consequences. Among these mediators, lipoxins were the first described and their pro-resolving actions have been mainly described in immune cells. They exert their actions mostly through formyl-peptide receptor 2 (ALX/FPR2 receptor), a G-protein-coupled receptor whose biological function is tremendously complex, primarily due to its capacity to mediate variable cellular responses. Moreover, lipoxins can also interact with alternative receptors like the cytoplasmic aryl hydrocarbon receptor, the cysteinyl-leukotrienes receptors or GPR32, triggering different intracellular signaling pathways. The available information about this complex response mediated by lipoxins is addressed in this review, going over the different mechanisms used by these molecules to stop the inflammatory reaction and avoid the development of dysregulated and chronic pathologies.

Keywords: ALX/FPR2; AhR; CysLT; GPR32; Lipoxins; Resolution.

Publication types

  • Review

MeSH terms

  • Humans
  • Inflammation
  • Lipoxins* / metabolism
  • Receptors, Formyl Peptide / metabolism
  • Receptors, Lipoxin / metabolism
  • Signal Transduction

Substances

  • Lipoxins
  • Receptors, Formyl Peptide
  • FPR2 protein, human
  • Receptors, Lipoxin